Pharmaceutical assessment of low global warming potential alternatives to HFA-134a in a budesonide, glycopyrrolate, and formoterol fumarate pressurized metered-dose inhaler.
Saved in:
| Title: | Pharmaceutical assessment of low global warming potential alternatives to HFA-134a in a budesonide, glycopyrrolate, and formoterol fumarate pressurized metered-dose inhaler. |
|---|---|
| Authors: | Lachacz K; Global Product Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, Gothenburg, Sweden. Electronic address: kellisa.lachacz@astrazeneca.com., Kaye R; Pharmaceutical Technology & Development, Operations, AstraZeneca, Cambridge, UK., Mello L; Global Product Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, Durham, NC, USA., Stoker A; Global Product Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, Durham, NC, USA., Törnell J; Global Product Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, Gothenburg, Sweden. |
| Source: | Journal of pharmaceutical sciences [J Pharm Sci] 2026 Oct; Vol. 115 (10), pp. 104458. Date of Electronic Publication: 2026 Aug 12. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 2985195R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-6017 (Electronic) Linking ISSN: 00223549 NLM ISO Abbreviation: J Pharm Sci Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1520-6017 |
|---|---|
| DOI: | 10.1016/j.xphs.2026.104458 |
